Today’s clinical trials are redefining the way we engage with patients. By designing the trial with the patient instead of for the patient, you get the benefits of personalized trial design and optimized study conduct enhanced by technologies and services. In the white paper Patient-Centricity by Design, experts from IQVIA discuss ways patient preferences have influenced the design and delivery of clinical trials while improving study efficiency and patient engagement.
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact [email protected] or call 202-824-5074.
